Navigation Links
ThermoGenesis Announces FDA Authorization to Market MarrowXpress(TM) (MXP(TM))
Date:7/14/2008

se actual outcomes to differ materially from those contemplated by the forward-looking statements. Several factors, including timing of FDA approvals, changes in customer forecasts, our failure to meet customers' purchase order and quality requirements, supply shortages, production delays, changes in the markets for customers' products, introduction timing and acceptance of our new products scheduled for fiscal year 2009, and introduction of competitive products and other factors beyond our control, could result in a materially different revenue outcome and/or in our failure to achieve the revenue levels we expect for fiscal 2009. A more complete description of these and other risks that could cause actual events to differ from the outcomes predicted by our forward-looking statements is set forth under the caption "Risk Factors" in our annual report on Form 10-K and other reports we file with the Securities and Exchange Commission from time to time, and you should consider each of those factors when evaluating the forward-looking statements.

ThermoGenesis Corp.

Web site: http://www.thermogenesis.com

Contact: Investor Relations

+1-916-858-5107, or

ir@thermogenesis.com


'/>"/>
SOURCE ThermoGenesis Corp.
Copyright©2008 PR Newswire.
All rights reserved

Page: 1 2 3 4

Related biology technology :

1. ThermoGenesis Announces Receipt of CE Mark for MarrowXpress(TM)
2. ThermoGenesis Names Dr. Mahendra Rao to Board of Directors
3. ThermoGenesis Subsidiary Vantus Announces Stem Cell Agreement With UC Davis Center For Equine Health
4. ThermoGenesis Corp. Announces Voluntary Recall of Selected Lots of AXP Bag Sets
5. ThermoGenesis Corp. Reports 48 Percent Growth in Second Quarter Revenues Year Over Year
6. ThermoGenesis Corp. to Announce Second Quarter Fiscal 2008 Results on February 6, 2008
7. ThermoGenesis Corp. to Announce First Quarter Fiscal 2008 Results on November 8, 2007
8. ThermoGenesis Corp. to Present at 2007 Global Life Sciences Conference on Thursday, September 27, 2007
9. ThermoGenesis Corp. Reports Fourth Quarter and Fiscal Year 2007 Results
10. ThermoGenesis Corp. to Announce Fourth Quarter and Year End Results for Fiscal Year 2007 on September 12, 2007
11. NuVasive Announces Web Cast and Conference Call of Second Quarter 2008 Results
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:12/22/2014)... Dec. 22, 2014  ( www.competitivehealth.com ) — Competitive ... medical bill review and advocacy service, has signed an ... WellCard Savings discount health services marketplace. 63% ... more than they expected to pay. As part of ... costs, WellCard Savings is pleased to offer medical bill ...
(Date:12/22/2014)... 22, 2014 Fertility Associates of Memphis ... Bank USA , a network of more than 20 ... partnership, patients have fast access to a national pool ... IVF . Fertility Associates of Memphis is the only ... treatment option. , Dr. William Kutteh , director ...
(Date:12/19/2014)... BioPlus Specialty Pharmacy (BioPlus), one ... of Nick Maroulis, Pharm.D. to the newly created position ... In this position, Dr. Maroulis will continue to manage ... of our multi-site pharmacies as the company expands. Dr. ... that time he has served in many different capacities ...
(Date:12/19/2014)... Dec. 19, 2014 Bina Technologies, Inc. (Bina, ... that they have been acquired by Roche (SIX: RO, ... privately held company that provides a big data platform ... (NGS) data for the academic and translational research markets. ... and will continue to focus on development of their ...
Breaking Biology Technology:WellCard Savings Announces CoPatient Medical Bill Review Service for Members 2Fertility Associates of Memphis Announces Partnership with Donor Egg Bank USA 2Fertility Associates of Memphis Announces Partnership with Donor Egg Bank USA 3BioPlus Specialty Pharmacy Promotes Dr. Nick Maroulis to Vice President of Specialty Pharmacy Services 2Bina Technologies is acquired by Roche. 2Bina Technologies is acquired by Roche. 3
... 4, 2011 Radient Pharmaceuticals Corporation (OTCQX:RXPC) (OTCPK:RXPC), a ... (IVD) cancer tests, today announced that all six proxy ... The Company,s proxy statement was filed with ... is available at www.sec.gov and on the ...
... N.C., Nov. 4, 2011 NeuroCog Trials, Inc. today ... the position of Chief Operating Officer.  In this newly ... continued growth and expansion of NeuroCog Trials, business, research ... research and development for pro-cognitive therapies across a wide ...
... 4, 2011 Major milestone achieved in ... of patients with refractory ascites due to liver cirrhosis. ... and Vienna General Hospital (AKH Wien) reported that the ... were performed at Vienna General Hospital in October, under ...
Cached Biology Technology:Radient Pharmaceuticals Announces Proxy Resolutions Approved at Special Meeting of Stockholders 2NeuroCog Trials Appoints Industry Executive Michael Hufford, Ph.D. to Chief Operating Officer 2The Medical University of Vienna and Vienna General Hospital Perform the First two Commercial Implants Worldwide of Sequana Medical's ALFApumpĀ® System 2
(Date:12/3/2014)... , Dec. 2, 2014   Marvin Test ... innovative test solutions for military, aerospace, and manufacturing ... of its successful TS-900 PXI semiconductor test ... features of high-end systems to customers at a ... compared to traditional ATE. "Our ...
(Date:11/21/2014)... -- Earlier this year Donald Spector , Chairman of ... the most prolific inventors in the world, got a ... to third party agencies. Spector envisioned this technology even ... earliest known patents in this area. Now major technology ... care, elder care and hospital applications. This technology has ...
(Date:11/21/2014)... JOSE, Calif. , Nov. 20, 2014   ... global leader in microcontroller (MCU) and touch technology solutions, ... digital temperature sensors with the widest V cc ... delivers higher temperature accuracy and faster I 2 C ... registers and serial EEPROM memory making them ideal for ...
Breaking Biology News(10 mins):Marvin Test Solutions Brings New Capabilities to PXI-Based Semiconductor Test with TS-960 2Marvin Test Solutions Brings New Capabilities to PXI-Based Semiconductor Test with TS-960 3Patented Biosensor Wearable Technology Provides a More Civilized Method of Quarantine 2Patented Biosensor Wearable Technology Provides a More Civilized Method of Quarantine 3Patented Biosensor Wearable Technology Provides a More Civilized Method of Quarantine 4Atmel Launches Industry's First Wide-V(cc) Low-Power Temperature Sensor Family 2Atmel Launches Industry's First Wide-V(cc) Low-Power Temperature Sensor Family 3Atmel Launches Industry's First Wide-V(cc) Low-Power Temperature Sensor Family 4
... Engineering established to be a world leading centre in ... Excellence (RCE) supported by NRF and MOE, bringing the ... 2007 , , 1. The National Research Foundation (NRF) and ... support for a Research Centre of Excellence (RCE) called ...
... of reports, the ACSS has collected a number of stories ... that will improve everyone,s wellbeing. The impact of social science ... re-employment to healthy diets and the wellbeing of children. ... will present her research on the value of fathers and ...
... 10, 2010) The American Psychiatric Association today released ... of Diagnostic and Statistical Manual of Mental Disorders (DSM). ... consideration for DSM, which is the standard classification of ... professionals, and is used for diagnostic and research purposes. ...
Cached Biology News:NTU sets up centre on micro-organism research for environmental engineering and sustainability 2NTU sets up centre on micro-organism research for environmental engineering and sustainability 3NTU sets up centre on micro-organism research for environmental engineering and sustainability 4APA announces draft diagnostic criteria for DSM-5 2APA announces draft diagnostic criteria for DSM-5 3APA announces draft diagnostic criteria for DSM-5 4APA announces draft diagnostic criteria for DSM-5 5
... The lyophilization stabilizer is designed ... process and for long-term storage. ... toxic ingredients. It is a ... pH 7.2, and is superior to ...
... coating stabilizer is designed for stabilizing ... and antibodies for immunoassay development. ... during the coating and drying process ... It can also works as a ...
... Clinical is Tecans open platform for clinical ... safety and performance in the clinical diagnostic ... by flexible barcode reading and sample traceability ... the system complies with the IVD-Directive* established ...
... the smallest thermal cyclers on the market, which ... 0.5ml (20 samples) or 0.2ml microtube (25 samples) ... and cooling rate of 3.6C/sec and 2.0C/sec respectively ... Fast track programming with new quick dial facility ...
Biology Products: